GB201905878D0 - Retentive formulation - Google Patents
Retentive formulationInfo
- Publication number
- GB201905878D0 GB201905878D0 GBGB1905878.3A GB201905878A GB201905878D0 GB 201905878 D0 GB201905878 D0 GB 201905878D0 GB 201905878 A GB201905878 A GB 201905878A GB 201905878 D0 GB201905878 D0 GB 201905878D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- retentive formulation
- retentive
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1905878.3A GB201905878D0 (en) | 2019-04-26 | 2019-04-26 | Retentive formulation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1905878.3A GB201905878D0 (en) | 2019-04-26 | 2019-04-26 | Retentive formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201905878D0 true GB201905878D0 (en) | 2019-06-12 |
Family
ID=66809141
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1905878.3A Ceased GB201905878D0 (en) | 2019-04-26 | 2019-04-26 | Retentive formulation |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201905878D0 (en) |
-
2019
- 2019-04-26 GB GBGB1905878.3A patent/GB201905878D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2592822B (en) | Therapeutic compositions | |
GB201807942D0 (en) | Pharmaceutical formulation | |
EP4125815A4 (en) | Therapeutic compositions | |
ZA202006570B (en) | Pharmaceutical formulations | |
IL285674A (en) | Pharmaceutical formulations | |
ZA202102871B (en) | Pharmaceutical formulation | |
IL278927A (en) | Pharmaceutical formulation | |
IL290894A (en) | Pharmaceutical formulation | |
GB201904338D0 (en) | Fluorouracil-containing formulations | |
IL284688A (en) | Formulation | |
PT4045038T (en) | New formulations | |
IL290356A (en) | Larazotide formulations | |
IL284691A (en) | Formulations | |
GB201913232D0 (en) | Aerosolisable formulation | |
GB201906473D0 (en) | Pharmaceutical formulation | |
SG11202010792TA (en) | Improved pharmaceutical formulations | |
GB201905878D0 (en) | Retentive formulation | |
GB202115200D0 (en) | Retentive formulation | |
GB2587402B (en) | Formulation | |
GB201906242D0 (en) | Aerosolisable formulation | |
GB201900658D0 (en) | Formulation | |
GB201911063D0 (en) | Formulations | |
GB201905105D0 (en) | Formulations | |
SG11202011823SA (en) | Activator-nucleator formulations | |
GB201909868D0 (en) | Therapeutic compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |